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Abstract
Background: The prevalence of allergic disease has risen 
significantly during recent years. A major component of the 
susceptibility to allergic disease is determined in prenatal life, when 
the placenta plays a central role in fetal growth and development. 
In this study, we aimed to identify the patterns of gene expression 
in the placenta that may program early immune function to increase 
susceptibility to allergy.
Methods: A set of immune genes known to be associated with asthma, 
allergy and inflammation were selected for analysis by quantitative 
real-time polymerase chain reaction (qRT-PCR) on placental tissue 
from infants who did or did not develop an allergy by 2 years of age. 
Analysis was performed on males and females separately for each 
allergy type including eczema, rhinitis or asthma.
Results: Of 11 candidate allergy-associated genes tested by 
qRT-PCR, 4 were found to be associated with the development of 
specific childhood allergy types (P < 0.05). These included MMP9 
for both males and females that developed eczema, TLR7 for 
females that developed eczema, KITL1 for males that developed 
rhinitis and ORMDL3 for females that developed asthma.
Conclusions: This study has identified altered expression of 
placental genes involved in inflammation in association with 
the development of specific allergies in childhood. The current 
data provide supporting evidence implicating the placenta in 
programming the fetal immune system in early life.
Keywords
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Introduction
There has been an epidemic rise in allergic disease since the 
second-half of the twentieth century, particularly in Western countries 
[1,2]. Diseases such as eczema, allergic rhinitis and food allergies 
now represent significant burdens to human health. Australia has 
one of the highest rates of allergic disease, with allergic sensitisation 
evident in up to 40% of children and asthma accountable as the 
most common cause of chronic disease in childhood [3,4]. It is now 
clear that developmental events play a critical role in determining 
susceptibility to allergy [5-7]. Exposures during pregnancy, when 
developing fetal systems are particularly vulnerable to environmental 
influences, could have significant effects on the programming of 
disease susceptibility [8].
The placenta plays a central role in fetal growth and development 
and acts as the immunological and metabolic interface between the 
mother and fetus. It has been demonstrated that levels of immune 
mediators detected in the fetus, of which the placenta is the major 
source, correlate with subsequent development of allergy [9]. 
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Furthermore, reduced mRNA levels of regulatory T cell (TREG) 
marker, FOXP3, have been reported in the placentae of infants who 
subsequently developed an allergic disease [10]. Thus, the placenta 
has great potential to program the fetal immune system, potentially 
increasing the susceptibility to allergy after birth. The concept of 
altered placental gene expression influencing fetal programming is 
supported by a recent study in mice. Knockout of the placenta-specific 
insulin-like growth factor-2 (Igf2) P0 transcript (Igf2-P0 KO) created 
an imbalance between fetal nutritional demand and placental supply 
of nutrients, leading to the offspring displaying significantly increased 
anxiety in later life [11]. Defining the molecular mechanisms in the 
placenta that may be altered in association with childhood allergy 
is vital for identifying causal pathways of altered fetal immune 
programming that increase the risk of allergy susceptibility.
Previous work by our team has demonstrated that the human 
placenta functions in a sex specific manner with significant 
differences in global gene and protein expression [12]. In particular 
there are significant differences in the placental immune response 
to the presence of maternal allergy [13] and its regulation by 
glucocorticoids between male and female placentae [14] with female 
placentae appearing more sensitive to an immune challenge and 
glucocorticoids relative to male placentae. These findings suggest that 
any placental immune dysregulation that leads to the susceptibility to 
allergy in later life may be vary in a sex specific manner.
In this study, we hypothesised that childhood susceptibility 
to allergy is increased by significant alterations in the in utero 
environment which include sex specific alterations in placental 
function that may program the development of the fetal immune 
system. We aimed to identify genetic pathways altered in the placentae 
of children who subsequently developed allergy in early childhood 
and to explore whether there are differences in relation to the allergic 
phenotype a child develops. We also aimed to determine whether 
there are sex differences in the expression profile. To do this, we 
selected a set of genes with immune functions known to be associated 
with asthma, allergy and inflammation for analysis on placental tissue 
from male or female infants who did or did not develop an allergy 
in early childhood. While the immune genes examined in this study 
were not exhaustive of those previously associated with allergy, we 
have chosen a select number of strong candidates for investigation in 
this study based on preliminary findings of placental microarray work 
comparing children with and without allergy by 4 years of age. From 
these, we have identified several immune genes that are associated 
with the development of specific childhood allergy phenotypes.
Methods and Materials
Study participants
This work was approved by the Government of South Australia 
(SA) Health Human Research Ethics Committee (TQEH/LMH/MH) 
         
Figure 1:  Gene expression levels in placentae of offspring with eczema compared to placentae from offspring without eczema. The solid bar indicates the 
median. Genes are expressed relative to β-actin. Male no eczema n = 14, male eczema n = 14, female no eczema n = 15, female eczema n = 11.* indicates 
significantly different to no allergy, P < 0.05 (Mann-Whitney U test).
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and the University of Adelaide Human Research Ethics Committee 
(2009045). Women were recruited from the antenatal clinic at the 
Lyell McEwin Hospital (Elizabeth, South Australia, Australia) during 
the first trimester of their pregnancy following written, informed 
consent. Women who smoked during pregnancy were excluded. 
Women were assessed throughout pregnancy at 12, 18, 30 and 36 
weeks for atopic status, diet and fetal growth. Placentae were collected 
within 45 minutes of delivery and multiple samples from the central 
and peripheral regions of the maternal side of placenta were pooled 
together, snap frozen and stored at -80°C.
Follow-up data was collected on infants every 12 months from 
6 months of age until 36 months of age. Allergy (asthma, rhinitis 
and eczema, but not food allergy) was determined by their general 
practitioner and/or allergy specialist and reported to the parent, 
who then completed a modified version of the International Study 
of Asthma and Allergy in Childhood (ISAAC) questionnaire [15,16], 
delivered at each follow-up visit. ISAAC is a collaborative project 
which has developed a standardized methodology to describe the 
prevalence and severity of asthma, rhinitis and eczema in children 
throughout the world [15,16]. Key questions from the ISAAC 
questionnaire were used to gather data on symptoms of asthma, 
allergic rhinitis, and atopic eczema. Rhinitis was defined if the parents 
reported “Yes” to the question, “Has your child ever had hayfever?”, 
or if parents responded yes to both questions, “In the last 12 months, 
has your child had a problem with sneezing, or a runny, or a blocked 
nose when he/she DID NOT have a cold or the flu?” and “In the last 
12 months, has this nose problem been accompanied by itchy/watery 
eyes?” Eczema was defined if the parents reported “Yes” to any one 
of the following questions: “In the last 12 months, has your child had 
a dry itchy rash at any time?” and “Has your child ever had eczema?” 
Asthma was defined at the 36 month visit if the parents reported 
“Yes” to the question, “Has your doctor ever told you that your child 
has asthma?”
RNA extraction
Total RNA was extracted from frozen placental tissue using the 
Trizol method as previously described [14,17]. RNA concentration 
was measured using an IMPLEN spectrophotometer, and RNA 
quality and integrity was assessed using a 2100 Bioanalyser 
(Agilent Technologies, Santa Clara, CA, USA). Only RNA samples 
demonstrating intact 28S and 28S rRNA peaks and a high RNA 
integrity number (RIN) (> 6) were included in the study. Reverse 
transcription was performed on 1 µg of total RNA using the iScript 
cDNA Synthesis kit (Biorad, Hercules, CA, USA) according to the 
manufacturer’s instructions.
Quantitative RT-PCR
Taqman Gene Expression Assays (Life Technologies, Carlsbad, 
CA, USA) were used to measure expression of putative allergy-
associated genes (identified following microarray analysis, data 
         
Figure 2:  Gene expression levels in placentae of offspring with either rhinitis or asthma compared to placentae from offspring without rhinitis or asthma. The 
solid bar indicates the median. Genes are expressed relative to β-actin. Male no rhinitis n = 15, male rhinitis n = 13, female no rhinitis n = 14, female rhinitis 
n = 12, male no asthma n = 7, male asthma n = 21, female no asthma n = 10, female asthma n = 16. * indicates significantly different to no allergy, P < 0.05 
(Mann-Whitney U test).
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not included as it was a preliminary assessment) in male (n = 28) 
and female (n = 26) placentae. Target genes are listed in table 2 
and figure 1 and figure 2. qRT-PCR was performed using the 7500 
Fast Real-Time PCR System (Applied Biosystems, Mulgrave, VIC, 
Australia) according the manufacturer’s instructions, and two 
technical replicates were included for each sample per assay. PCR 
data was analysed using the 2-ΔΔCt method, with expression of each 
gene normalised to β-actin expression as used previously for gene 
expression analyses of placental tissue [18,19].
Statistical analysis
Statistical analyses were performed with SPSS Statistics software 
(version 20, Statistical Package for Social Sciences, SPSS Inc, IBM, 
Chicago, IL). All data are expressed as median unless otherwise 
indicated. Sex differences in gene expression between individuals with a 
specific allergy type relative to individuals without an allergy were tested 
using non-parametric Mann-Whitney U tests. Non-parametric Kruskal 
Wallace analysis of variance (KW-ANOVA) was used to compare all 
groups by sex and allergy phenotype. The impact of maternal asthma on 
placental gene expression was also examined using Mann-Whitney U 
tests to determine whether any changes observed in the placenta may be 
related to the presence of maternal disease.
Results
Characteristics of study populations
Maternal characteristics between “no allergy” and “allergy” study 
groups were not significantly different. The mean age and BMI of 
mothers in the “no allergy” group was 29.8 years of age and 25.7, while 
the mean age was 27.1 years and mean BMI was 28.3 in the “allergy” 
group. Neonatal characteristics are summarised in supplementary 
table 1. Maternal and neonatal characteristics of each study group are 
summarised in table 1.
Quantitative RT-PCR of selected genes
Some placental genes identified from the preliminary microarray 
work that were selected for analysis were not found to vary significantly 
in relation to allergic phenotype and so have been listed in table 2.
Placental genes altered in association with childhood eczema
Expression of matrix metallopeptidase 9 (MMP9) mRNA was 
reduced in placentae from males and females with eczema compared 
to placentae from males females without eczema (Mann Whitney 
U test, males: P = 0.039, females: P = 0.039) (Figure 1A and 1B). 
Overall, MMP9 levels were significantly higher in males than females 
in subjects with eczema (KW-ANOVA, P = 0.048, data not shown) 
Levels of Toll-like receptor 7 (TLR7) did not differ in males with or 
without eczema (Figure 1C), but was lower in placentae of females 
with eczema compared to placentae of females without eczema 
(Figure 1D).
Placental genes altered in association with childhood 
rhinitis
Levels of kit ligand 2 (KITL2) mRNA were very low or absent with 
Cq values over 35, and thus was not included in statistical analyses. 
Kit ligand 1 (KITL1) expression was significantly higher in placentae 
from males with rhinitis compared to placentae from males without 
rhinitis (P = 0.041) (Figure 2A), while expression did not differ 
between placentae from females with or without rhinitis (Figure 2B).
Placental genes altered in association with childhood asthma
Expression of ORM (yeast)-like protein isoforms 3 (ORMDL3) 
mRNA did not differ between the placentae of males with or without 
asthma, but was reduced in the placentae of females with asthma 
compared to the placentae of females without asthma (P = 0.027) 
(Figure 2D).
Relationship of placental gene expression to maternal 
asthma during pregnancy
We assessed whether there was any relationship between maternal 
asthma and changes in gene expression, as asthma is a significant risk 
factor that increases the likelihood of offspring developing allergy 
[20]. As shown in supplementary table 2, the presence or absence 
of maternal asthma was not significantly associated with any of the 
placental genes identified to be associated with childhood allergy.
Discussion
In this study, we have shown that a number of genes expressed 
in the placenta at birth are differentially expressed in association 
with the subsequent development of childhood eczema, rhinitis and 
asthma. This data supports the current hypothesis that in utero events 
may pre-program the fetal immune system to an allergic phenotype 
[21]. Our results indicate that placentae of children who subsequently 
develop allergy have a bias towards a Th2 immune profile which 
varied sex specifically. These data suggest that both sex-specific and 
gene-specific mechanisms may underlie the development of each 
allergy.
Table 1: Maternal characteristics during pregnancy and neonatal characteristics
RHINITIS ASTHMA ECZEMA
No Yes No Yes No Yes
Male Female Male Female Male Female Male Female Male Female Male Female
n 15 14 13 12 7 10 21 16 14 15 14 11
Maternal 




26.3 ± 5.0 27.3 ± 4.0 28.8 ± 6.2 28.7 ± 6.6 28.6 ± 5.8 26.1 ± 4.0 25.4 ± 5.1 30.9 ± 6.1 27.6 ± 4.8 25.9 ± 4.2 28.2 ± 5.8 29.5 ± 7.1
Gravida 2.1 ± 1.3 2.3 ± 1.3 2.0 ± 1.1 1.9 ± 1.2 2.4 ± 1.8 1.8 ± 0.7 1.9 ± 0.9 2.4 ± 1.3 2.2 ± 1.4 2.2 ± 1.3 1.8 ± 0.9 2.0 ± 1.2
Parity 1.9 ± 1.3 2.0 ± 1.0 1.5 ± 0.9 1.7 ± 0.8 2.3 ± 1.8 1.6 ± 0.7 1.5 ± 0.8 2.0 ± 1.1 1.9 ± 1.4 1.9 ± 1.0 1.5 ± 0.9 1.7 ± 1.0
% maternal 
asthma 80.0 42.9 53.4 58.3 85.7 30.0 61.9 62.5 71.4 46.6 64.2 54.5
Gestational 
age (days) 278 ± 10 278 ± 8 277 ± 10 276 ± 12 276 ± 9 278 ± 9 277 ± 10 276 ± 12 275 ± 9 280 ± 9 277 ± 12 276 ± 10
Birthweight 
(g) 3661 ± 311 3525 ± 505 3474 ± 467 3593 ± 563 3681 ± 192 3570 ± 461 3391 ± 368 3615 ± 571 3511 ± 291 3685 ± 498 3390 ± 447 3718 ± 542
Birth weight 
centile 56.8 ± 25.2 47.1 ± 32.9 50.4 ± 29.9 65.5 ± 31.7 60.0 ± 25.8 49.6 ± 28.4 49.6 ± 28.4 62.2 ± 32.5 48.4 ± 28.5 56.1 ± 29.8 46.0 ± 30.8 72.8 ± 25.1
Mean ± standard deviation
Table 2: Inflammatory genes selected for analysis in the placenta that were not 
altered in relation to childhood allergy.
Gene name Description
FOXO1 forkhead box O1
CXCR1 chemokine (C-X-C motif) receptor 1
VEGFA vascular endothelial growth factor A
MMP2 matrix metallopeptidase 2
ALOX15 15-lipoxygenase
KIT c-kit
MAOB monoamine oxidase B
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We identified two genes associated with the development of 
eczema, specifically MMP9 in males and TLR7 in females. TLR7 is an X 
chromosome gene which does not escape X inactivation; however, it has 
been suggested that epigenetic mechanisms may cause altered expression 
between males and females. TLR7 promotes a Th1-type immune 
response via differentiation of Th1 cells and production of cytokines, and 
strong evidence indicates that it is protective against the development 
and severity of allergic disorders [22-25]. Decreased mRNA in placentae 
from females who subsequently developed eczema may drive decreased 
placental Th1 cytokine activation including IFNγ, IFNα, TNFβ, IL-3 
and GM-CSF [22-25] (summary in Figure 3). A reduction in these pro-
inflammatory cytokines may influence T cell differentiation including 
CD8 + cells [26], T regulatory cells [27] and dendritic cells in the fetus 
[28], thereby increasing susceptibility to developing eczema.
There may also be a bias towards a Th2 response in male eczema via 
different mechanisms. MMP9 plays a significant role in inflammation 
by facilitating cellular traffic, including neutrophils and eosinophils, via 
degradation of extracellular matrix and establishment of chemokine 
gradients [29]. Importantly, upregulation of MMP9 mRNA has been 
demonstrated to be concomitant with the recruitment of Th2 cells in 
mice [29], while MMP9-null mice showed a marked attenuation of 
the Th2 inflammatory response [30]. Altered expression of MMP9 in 
placentae may result in altered immune cell trafficking and increased 
Th2 activation, including elevated numbers of CD4+ cells and release 
of inflammatory cytokines leading to increased susceptibility to 
developing eczema in male offspring (Figure 3).
This study has shown an association between increased KITL1 
         
γ
Figure 3: Proposed model of mechanisms underlying increased susceptibility to specific allergy types in females and males.
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expression in male placentae and subsequent development of 
rhinitis, supporting mouse studies demonstrating KITL to be 
involved in the development of allergic inflammation [31-33]. 
We found no differences in expression of the KITL receptor, c-kit, 
suggesting that any influences of the KITL/c-kit signalling pathway 
on the programming of the fetal immune system are exerted 
through elevated KITL expression alone. Abnormal KITL1 gene 
expression may contribute towards a skewed Th2 immune profile by 
promoting infiltration of inflammatory cells including eosinophils 
and leukocytes, and increased production of Th2 cytokines IL-4 and 
IL-5 [33].
Interestingly, this study identified decreased expression of ORMDL3 
to be associated with the development of asthma in females. To our 
knowledge, no study has characterised the association of ORMDL3 with 
asthma by sex; thus, this is the first study to demonstrate a sex-specific 
association between ORMDL3 and asthma. Increased ORMDL3 has 
recently been identified as being strongly associated with both childhood 
and adult asthma [34-42]. Therefore, it is somewhat surprising that our 
study has observed decreased expression in association with asthma. The 
mechanisms underlying ORMDL3 function and its effects on asthma 
are unclear and studies have reported conflicting results. Notably, an in 
vitro study demonstrated that ORMDL3 reduced T-cell activation via 
an important immune activation mechanism [43]. Overexpression of 
ORMDL3 in a T-cell line inhibited store-operated Ca2+ influx, thereby 
reducing nuclear translocation of the nuclear factor of activated T-cells 
(NFAT) [43]. It is clear that the contribution of ORMDL3 to the 
pathogenesis of asthma is quite complex and requires further study.
The presence of maternal allergy is a significant risk factor that 
increases the likelihood of offspring developing allergy [20]. Pregnancies 
complicated by asthma can have a significant effect on placental gene 
expression and potentially contribute to an atopic phenotype in offspring. 
We have previously shown that pregnancies complicated by maternal 
asthma are associated with reduced female fetal growth, accompanied by 
alterations in placental function such as decreased placental 11β-HSD2 
[44]. However, the placental immune genes identified that were altered 
in the presence of maternal asthma including TNFα, IL-1β, IL-6, IL-8, 
IL10 and IL-5 [13] were not altered in the placentae of children who 
developed allergy. Furthermore, we did not find any association between 
maternal asthma and altered gene expression in placentae of children 
that developed an allergy. This suggests that certain immune mechanisms 
that are altered in the fetal-placental unit by the presence of maternal 
asthma are not associated with gene alterations associated with allergy 
susceptibility in early childhood.
In conclusion, this study has demonstrated a number of placental 
genes that are altered in association with the development of specific 
childhood allergic phenotypes and suggests the in utero environment 
may play a role in programming the immune system. The potential 
mechanisms driving increased susceptibility to allergy via these 
altered genes are illustrated in our proposed model in figure 3. Based 
on this model we propose that abnormal expression of these genes in 
the placenta may cause a bias towards a Th2 immune profile in the 
fetal circulation including increased levels of CD4+ cells, increased 
secretion of anti-inflammatory cytokines and decreased Treg activity 
as previously indicated by reduced placental FOXP3 expression [10]. 
As a result, altered programming of fetal immune function may result 
in increased susceptibility allergic disease.
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